STUB1 and acute myeloid leukemia: Establishing murine models that recapitulate CHIP may lead to a better understanding of the underlying mechanisms of this phenomenon, to the development of better therapeutic strategies targeting pre-leukemic HSCs and potentially provide the opportunity to intervene before the onset of AML.